Glycobiology Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024 The term glycobiology, also called as glycans, is the study of structure, function and biology of carbohydrate. They are the most essential components in living things. Merton Bern field and colleagues discovered the first syndecans, which is a core protein with sugars attached to the cell surfaces that control or influence tissue repair, metabolism, formation of tumors and development of immune responses. Syndecan plays an important role in obesity, cancer and bacterial pathogenesis. Drugs such as heparin, erythropoietin and some of anti-flue drugs have proven effective and exhibit the importance of glycans as a new class of drugs. Not only in pharmaceuticals, glycobiology are used in various fields such as biotechnology, material science, marine science, food & beverages and many others. New technologies such as carbohydrate microarray have overcome the hurdles involved in the research in the field of glycobology by allowing high yield screening and analysis of protein-glycan interactions. Browse
Complete
Report
@
https://www.variantmarketresearch.com/report-
categories/life-sciences/glycobiology-market
Recent progress in chemical synthesis and bioengineering which has resulted in the development of carbohydrate-based vaccines, have boosted the growth of market. Moreover, increasing R&D expenditure by pharmaceutical companies and increasing funding through government bodies have elevated the growth of the market. However, complexity in the glycan structures makes it
Variant Market Research
difficult to produce large quantity of glycans, for instance, monosaccharide components have greatly different biological properties while having the same molecular composition, hence are indistinguishable by most analytical methods. Additionally, high production cost and low availability of skilled experts would restrict the growth of market. Furthermore, the search for new anti-cancer drugs and mergers and acquisition of major companies are opening up new possibilities for the market. Get Sample Copy of This Report @ http://bit.ly/2q5NMfc The glycobiology market is segmented based on the product, application, end-user and geography. Product is further segmented into instrument, kits, reagent and enzymes. Furthermore, application is segmented into oncology, diagnostics, drug discovery and development, immunology and others. Based on end-user, the market is segmented into pharmaceuticals & biotechnology companies, research institutes and contract research organizations. Additionally, based on geography, the glycobiology market is segmented into North America, Europe, Asia-Pacific and Rest of world (RoW). The key players are Merck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermos Fisher Scientific, Inc., Shimadzu Corporation, Plex era Bioscience LLC, New England Biolabs Inc., Agilent Technologies, Inc., and ProZyme, Inc. Scope of Glycobiology Market Product Segments •
Instrument
•
Kits
•
Reagent
•
Enzymes
Application Segments •
Oncology
•
Diagnostics
•
Drug Discovery and Development
•
Immunology
•
Others
Variant Market Research
Geographical Segments •
•
•
•
North America o
US
o
Canada
o
Mexico
Europe o
Germany
o
France
o
United Kingdom
o
Spain
o
Others
Asia-Pacific o
China
o
India
o
Japan
o
South Korea
o
Others
RoW o
South America
o
Middle East
o
Africa
Contact Us: VARIANT MARKET RESEARCH LLP Web: https://www.variantmarketresearch.com/ USA Office: 649 Mission St., 5th Floor, San Francisco, CA 94105, United States. Tel: +1-415-680-2785 Fax: +1-415-680-2786 Email: help@variantmarketresearch.com Variant Market Research
India Office (Corporate Headquarter): Office No. FL No.7, Prakash Developers, Survey no 34/A5, Wadgaon Sheri, Nagar Road, Pune – 411014 Tel: +91 20 65337795
Variant Market Research